Empiric Carbapenem Therapy for Sepsis: Are We Winning the Battle at the Expense of the War?*

Department of Pharmacy Practice, Midwestern University, College of Pharmacy-Glendale Campus, Glendale, AZ. *See also p. 1210. Dr. Barletta is an elected member of Council of the Society of Critical Care Medicine (SCCM). The views presented are those of the author and do not represent the views of SCCM. He received funding from Wolters Kluwer; he disclosed the off-label product use of antibiotics in sepsis.